Cargando…
Mesenchymal Stem Cells Suppress Severe Asthma by Directly Regulating Th2 Cells and Type 2 Innate Lymphoid Cells
Patients with severe asthma have unmet clinical needs for effective and safe therapies. One possibility may be mesenchymal stem cell (MSC) therapy, which can improve asthma in murine models. However, it remains unclear how MSCs exert their beneficial effects in asthma. Here, we examined the effect o...
Autores principales: | Shin, Jae Woo, Ryu, Seungwon, Ham, Jongho, Jung, Keehoon, Lee, Sangho, Chung, Doo Hyun, Kang, Hye-Ryun, Kim, Hye Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424137/ https://www.ncbi.nlm.nih.gov/pubmed/34462397 http://dx.doi.org/10.14348/molcells.2021.0101 |
Ejemplares similares
-
Memory-like innate lymphoid cells in the pathogenesis of asthma
por: Ham, Jongho, et al.
Publicado: (2022) -
Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells
por: Ham, Jongho, et al.
Publicado: (2022) -
The Roles of Innate Lymphoid Cells in the Development of Asthma
por: Woo, Yeonduk, et al.
Publicado: (2014) -
Innate Lymphoid Cells in Tissue Homeostasis and Disease Pathogenesis
por: Kim, Jihyun, et al.
Publicado: (2021) -
Bone Marrow Progenitors and IL-2 Signaling Contribute to the Strain Differences of Kidney Innate Lymphoid Cells
por: Ryu, Seungwon, et al.
Publicado: (2023)